Traditional Chinese medicine composition for treating idiopathic thrombocytopenic purpura

Abstract

The invention relates to a traditional Chinese medicine composition for treating idiopathic thrombocytopenic purpura. The traditional Chinese medicine composition is prepared from the following raw pharmaceutical materials in parts by weight: 20-28 parts of raw milkvetch root, 15-20 parts of prepared ligustrum lucidum, 10-15 parts of atractylodes macrocephala, 12-18 parts of raw rehmannia root, 15-20 parts of dodder seed, 12-18 parts of tree peony bark, 12-18 parts of Jiangnan herba selaginellae, 12-18 parts of herba agrimoniae, 12-18 parts of aizoon stonecrop and 4-8 parts of prepared liquorice root. The invention further provides application of the traditional Chinese medicine composition. The traditional Chinese medicine composition has the advantages that the compatibility of the traditional Chinese medicine composition disclosed by the invention accords with the principle of monarch-and-minister-and-assistant-and-guide of the traditional Chinese medicine, the traditional Chinese medicine composition can effectively control the bleeding symptom of a sufferer, improve the quality of life and increase the number of platelets and has a remarkable treatment effect on idiopathic thrombocytopenic purpura, and no adverse reaction is caused, so that the traditional Chinese medicine composition has broad development and application prospects and is suitable for further popularization and application.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating immune thrombocytopenia. Background technique [0002] Immune thrombocytopenia, also known as Idiopathic thrombocytopenic purpura (ITP), is a type of spontaneous bleeding with decreased platelet count in the blood, normal or increased megakaryocytes in the bone marrow, and spontaneous bleeding in multiple parts and organs. common bleeding disorders. [0003] Clinically, the incidence of this disease has been on the rise in recent years. Western medicine treatment is mainly based on glucocorticoids, immunosuppressants and splenectomy, but the adverse reactions are unbearable for most patients and the quality of life is low. At present, the main first-line drugs for the treatment of ITP at home and abroad are hormone drugs such as prednisone and cortisone. The use of hormones for treatment mainly inhibi...

AI Technical Summary

Problems solved by technology

However, according to clinical statistics, the use of hormone drugs for treatment has the disadvantages of high recurrence rate, many side effects, and long course of treatment. Patients need to take long-term medication for treatment.

Images